AMONGCredit Agreement • October 1st, 1999 • Perrigo Co • Pharmaceutical preparations • Michigan
WITNESSETH:Consulting Agreement • September 6th, 2000 • Perrigo Co • Pharmaceutical preparations • Michigan
dated as ofCredit Agreement • May 5th, 2005 • Perrigo Co • Pharmaceutical preparations • Michigan
1 EXHIBIT 2(a) ASSET PURCHASE AGREEMENT Dated as of August 25, 1999Asset Purchase Agreement • October 1st, 1999 • Perrigo Co • Pharmaceutical preparations • Tennessee
RECITALCredit Agreement • November 2nd, 2006 • Perrigo Co • Pharmaceutical preparations
PERRIGO COMPANY RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • May 8th, 2007 • Perrigo Co • Pharmaceutical preparations • Michigan
1 EXHIBIT 10(h)Employment Agreement • April 26th, 2000 • Perrigo Co • Pharmaceutical preparations • Michigan
1 2 provide consulting services on matters relating to acquisitions and mergers and on such other corporate and operational matters, including, but not limited to, general financial matters, strategic issues, and international operations, as his...Consulting Services Agreement • February 9th, 2000 • Perrigo Co • Pharmaceutical preparations • Michigan
EXHIBIT 10(h) SECOND AMENDMENT TO REGISTRANT'S AGREEMENT, DATED NOVEMBER 20, 1998Credit Agreement • November 23rd, 1998 • Perrigo Co • Pharmaceutical preparations
EXHIBIT 10.1Employment Agreement • September 12th, 2006 • Perrigo Co • Pharmaceutical preparations • Michigan
EXHIBIT 10.2Employment Agreement • September 12th, 2006 • Perrigo Co • Pharmaceutical preparations • Michigan
Exhibit 10.1 AMENDMENT TO EMPLOYMENT AGREEMENT This Amendment to Employment Agreement is dated as of June 30, 2005 (this "Amendment") by and between Perrigo Company, a Michigan corporation (the "Company") and David T. Gibbons (the "Executive")....Employment Agreement • July 6th, 2005 • Perrigo Co • Pharmaceutical preparations • Michigan
Exhibit 10(b) THIRD AMENDMENT TO EMPLOYMENT AGREEMENT This Third Amendment to Employment Agreement is dated as of December 27, 2006 (this "Amendment") by and between Perrigo Company, a placeStateMichigan corporation (the "Company"), and David T....Employment Agreement • February 1st, 2007 • Perrigo Co • Pharmaceutical preparations
PERRIGO COMPANY 2.950% NOTES DUE 2023 UNDERWRITING AGREEMENTUnderwriting Agreement • May 10th, 2013 • Perrigo Co • Pharmaceutical preparations • New York
This Agreement will inure to the benefit of and be binding upon the parties hereto and their respective successors, but will not be assignable by either party hereto without the written consent of the other.
WITNESSETH:Consulting Agreement • September 18th, 2002 • Perrigo Co • Pharmaceutical preparations • Michigan
1 Exhibit 10(f) LOAN AGREEMENTLoan Agreement • October 6th, 1998 • Perrigo Co • Pharmaceutical preparations • Georgia
3 REPRESENTATIONS AND WARRANTIES OF FARBERStock Purchase Option Agreement • June 14th, 2004 • Perrigo Co • Pharmaceutical preparations • Delaware
Exhibit 10(d) INDEMNITY AGREEMENT This Agreement is made as of [Date], by and between PERRIGO COMPANY, a Michigan corporation (the "Company"), 515 Eastern Avenue, Allegan, Michigan 49010, and [Name]("Indemnitee"), whose address is [Address]. WHEREAS,...Indemnification & Liability • November 9th, 2006 • Perrigo Co • Pharmaceutical preparations • Michigan
SECTION 1Long-Term Incentive Award Agreement • May 8th, 2007 • Perrigo Co • Pharmaceutical preparations • Michigan
Exhibit 10.1 AMENDMENT NO. 2 TO NOMINATING AGREEMENT This Amendment No. 2 is dated as of September 10, 2005 (this "Amendment") by and between Perrigo Company, a Michigan corporation (the "Buyer") and Moshe Arkin (the "Shareholder") of Buyer. WHEREAS,...Nominating Agreement • September 14th, 2005 • Perrigo Co • Pharmaceutical preparations
CONTRACTLease Agreement • May 5th, 2005 • Perrigo Co • Pharmaceutical preparations
PURCHASE AGREEMENT by and among PERRIGO COMPANY, PADDOCK LABORATORIES, INC., PADDOCK PROPERTIES LIMITED PARTNERSHIP and, solely for purposes of Section 11.15, THE PERSONS SET FORTH ON EXHIBIT A Dated as of January 20, 2011Purchase Agreement • January 26th, 2011 • Perrigo Co • Pharmaceutical preparations • New York
THIS PURCHASE AGREEMENT, dated as of January 20, 2011 (this “Agreement”), is entered into by and among Perrigo Company, a Michigan corporation (“Purchaser”), Paddock Laboratories, Inc., a Minnesota corporation (the “Company”), Paddock Properties Limited Partnership, a Minnesota limited partnership (“Paddock Properties” and, with the Company, each a “Seller” and together the “Sellers”), and, solely for purposes of Section 11.15, each of the Persons set forth on Exhibit A (the “Guarantors”). Each Seller and Purchaser may be referred to herein individually as a “Party” and collectively as the “Parties”.
PERRIGO COMPANY SECOND SUPPLEMENT TO MASTER NOTE PURCHASE AGREEMENT Dated as of September 1, 2011 $75,000,000 4.27% Senior Notes, Series 2011-A, due September 30, 2021 $175,000,000 4.52% Senior Notes, Series 2011-B, due December 15, 2023 $100,000,000...Master Note Purchase Agreement • September 8th, 2011 • Perrigo Co • Pharmaceutical preparations • New York
On January 20, 2011, the Company signed a definitive agreement to acquire substantially all of the assets of Paddock Laboratories, Inc. (“Paddock”) for approximately $540,000,000 in cash. The Company closed the acquisition of Paddock on July 26, 2011. As part of the acquisition, the Company assumed all of the obligations and liabilities associated with the acquired assets (other than Paddock’s debt for money borrowed which was repaid as part of the closing). The Company funded the transaction using a combination of cash on hand, utilization of its existing credit facilities and a new five-year term loan. Concurrent with the signing of the Paddock agreement, the Company entered into a Term Loan Agreement (the “Agreement”). Under the terms of the Agreement, the term loan commitment is $250,000,000 and was funded in full in conjunction with the closing of the Paddock acquisition. The term loan has mandatory annual amortizations of $25,000,000 on each of the four annual anniversary dates w
DATED JULY 28, 2013 ELAN CORPORATION, PLC AND PERRIGO COMPANY AND LEOPARD COMPANY AND HABSONT LIMITED AND BLISFONT LIMITED TRANSACTION AGREEMENTTransaction Agreement • July 29th, 2013 • Perrigo Co • Pharmaceutical preparations • Michigan
EXHIBIT 10.2 SEPARATION AND GENERAL RELEASE AGREEMENT Mark P. Olesnavage ("Employee") and PERRIGO COMPANY ("Perrigo") enter into this Confidential Separation and General Release Agreement ("Agreement") to resolve all matters related to Employee's...Separation and General Release Agreement • July 6th, 2005 • Perrigo Co • Pharmaceutical preparations • Michigan
PERRIGO COMPANY RESTRICTED STOCK UNIT AWARD AGREEMENT (PERFORMANCE-BASED) (Under the Perrigo Company 2008 Long-Term Incentive Plan)Restricted Stock Unit Award Agreement • August 18th, 2009 • Perrigo Co • Pharmaceutical preparations • Michigan
This is to notify you that Perrigo Company (the “Company”) has granted you an Award under the Perrigo Company 2008 Long-Term Incentive Plan (the “Plan”), effective as of (the “Grant Date”). This Award consists of performance-based restricted stock units. The terms and conditions of this incentive are set forth in the remainder of this agreement (the “Agreement”). The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.
PERRIGO COMPANY NONQUALIFIED STOCK OPTION AGREEMENT (Under the Perrigo Company 2008 Long-Term Incentive Plan)Nonqualified Stock Option Agreement • August 18th, 2009 • Perrigo Co • Pharmaceutical preparations • Michigan
This is to notify you that Perrigo Company (the “Company”) has granted you an Award under the Perrigo Company 2008 Long-Term Incentive Plan (the “Plan”), effective as of (the “Grant Date”). This Award consists of a nonqualified stock option. The terms and conditions of this incentive are set forth in the remainder of this agreement (the “Agreement”). The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.
PERRIGO COMPANY FIRST SUPPLEMENT TO MASTER NOTE PURCHASE AGREEMENT Dated as of April 30, 2010 $115,000,000 4.91% Senior Notes, Series 2010-A, due April 30, 2017 $150,000,000 5.45% Senior Notes, Series 2010-B, due April 30, 2020 $150,000,000 5.55%...Master Note Purchase Agreement • May 5th, 2010 • Perrigo Co • Pharmaceutical preparations • New York
This First Supplement to Master Note Purchase Agreement (this “First Supplement” or this “Agreement”) is among PERRIGO COMPANY, a Michigan corporation (the “Company”), and the institutional investors named on the attached Schedule A (collectively, the “Purchasers”) hereto.
ADDENDUM TO THE EMPLOYMENT AGREEMENT BETWEEN SHARON KOCHAN, PERRIGO COMPANY AND AGIS INDUSTRIES (1983) LTD.Employment Agreement • August 18th, 2008 • Perrigo Co • Pharmaceutical preparations
This ADDENDUM, dated as of July 16, 2007, to the Employment Agreement dated as of November 14, 2004, is between Perrigo Company (the “Company”), and Sharon Kochan (the “Executive”).
CASH BRIDGE CREDIT AGREEMENT dated as of July 28, 2013 among BLISFONT LIMITED, as Borrower, THE LENDERS PARTY HERETO, HSBC BANK USA, N.A., as Syndication Agent and BARCLAYS BANK PLC, as Administrative Agent, BARCLAYS BANK PLC and HSBC SECURITIES (USA)...Cash Bridge Credit Agreement • July 29th, 2013 • Perrigo Co • Pharmaceutical preparations • New York
This CASH BRIDGE CREDIT AGREEMENT (this “Agreement”), dated as of July 28, 2013, is among Blisfont Limited, a private limited company organized under the laws of Ireland (the “Borrower”), as borrower, the LENDERS party hereto, HSBC BANK USA, N.A. as Syndication Agent and BARCLAYS BANK PLC, as Administrative Agent.
Dated 28 July 2013 ELAN CORPORATION, PLC and PERRIGO COMPANY EXPENSES REIMBURSEMENT AGREEMENT A&L GoodbodyExpenses Reimbursement Agreement • July 29th, 2013 • Perrigo Co • Pharmaceutical preparations
NOMINATING AGREEMENTNominating Agreement • November 18th, 2004 • Perrigo Co • Pharmaceutical preparations • New York
This NOMINATING AGREEMENT (this “Agreement”) is made as of November 14, 2004 between Perrigo Company, a Michigan corporation (“Buyer”), and the undersigned shareholder (“Shareholder”) of Agis Industries (1983) Ltd., an Israeli public company (the “Company”).
SECTION 1Long-Term Incentive Award Agreement • August 22nd, 2006 • Perrigo Co • Pharmaceutical preparations • Michigan
FIFTH AMENDMENT TO CREDIT AGREEMENTCredit Agreement • April 25th, 2008 • Perrigo Co • Pharmaceutical preparations
THIS FIFTH AMENDMENT TO CREDIT AGREEMENT, dated as of April 22, 2008 (this “Amendment”), is among Perrigo Company (the “U.S. Borrower”), the Foreign Subsidiary Borrowers party hereto, the Lenders party hereto, JPMorgan Chase Bank, N.A., as Administrative Agent for the Lenders (in such capacity, the “Administrative Agent”), Bank Leumi USA, as Syndication Agent, and Bank of America, N.A., LaSalle Bank Midwest National Association and National City Bank of the Midwest, as Documentation Agents.
UNDERTAKING AGREEMENTUndertaking Agreement • November 18th, 2004 • Perrigo Co • Pharmaceutical preparations • New York
This UNDERTAKING AGREEMENT (“Agreement”) is made as of November 14, 2004, between Perrigo Company, a Michigan corporation (“Buyer”), Agis Industries (1983) Ltd., an Israeli public company (the “Company”) and the undersigned shareholder (“Shareholder”) of the Company.
